Mechanisms of action of currently available woman-controlled, vaginally administered, non-hormonal contraceptive products

por Chappell, B. Todd, Griffin, Brooke L., Howard, Brandon
Publicado 2022

A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial()()()

por Thomas, Michael A., Chappell, B. Todd, Maximos, Bassem, Culwell, Kelly R., Dart, Clint, Howard, Brandon
Publicado 2020

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)

por Schwebke, Jane R, Sobel, Ryan, Gersten, Janet K, Sussman, Steven A, Lederman, Samuel N, Jacobs, Mark A, Chappell, B Todd, Weinstein, David L, Moffett, Alfred H, Azie, Nkechi E, Angulo, David A, Harriott, Itzel A, Borroto-Esoda, Katyna, Ghannoum, Mahmoud A, Nyirjesy, Paul, Sobel, Jack D
Publicado 2021